RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Bradenton, FL · Maitland, FL · Orlando, FL · +16 more sites
Clinical trials in Orlando, FL
236 recruiting studies have a site in or near Orlando, FL, Florida.
Top conditions here
- Lung Cancer (27)
- Crohn's Disease (21)
- Alzheimer's Disease (20)
- Breast Cancer (17)
- Ulcerative Colitis (17)
- Obesity (16)
- Prostate Cancer (16)
- Type 2 Diabetes (15)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 40 of 236 studies
RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Clearwater, FL · Fleming Island, FL · Jacksonville, FL · +56 more sites
RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Fort Lauderdale, FL · Hollywood, FL · Miami, FL · +452 more sites
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Aventura, FL · Fort Lauderdale, FL · Fort Myers, FL · +1147 more sites
RecruitingPhase 2NCT06317662
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Sponsor: National Cancer Institute (NCI)
Gainesville, FL · Hollywood, FL · Jacksonville, FL · +112 more sites
RecruitingNot applicableNCT06891755
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Sponsor: Apreo Health, Inc.
Jascksonville, FL · Orlando, FL · +16 more sites
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Boynton Beach, FL · Cutler Bay, FL · Doral, FL · +72 more sites
RecruitingPhase 2NCT07527650
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
DeLand, FL · Orlando, FL · +17 more sites
RecruitingPhase 3NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Atlantis, FL · Boca Raton, FL · Bonita Springs, FL · +145 more sites
RecruitingPhase 3NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Brooksville, FL · Clearwater, FL · Coral Gables, FL · +92 more sites
RecruitingPhase 1 / Phase 2NCT07038343
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Sponsor: Avenzo Therapeutics, Inc.
Orlando, FL · Sarasota, FL · Tampa, FL · +16 more sites
RecruitingPhase not listedNCT07878975
HRV Variation in Rheumatoid Arthritis
Sponsor: University of Central Florida
Orlando, FL
RecruitingPhase 2NCT05478707
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Sponsor: AdventHealth Translational Research Institute
Orlando, FL
RecruitingPhase 1NCT06545331
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Orlando, FL · +15 more sites
RecruitingPhase 2NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sponsor: Sanofi
Kissimmee, FL · Lighthouse PT, FL · Miami, FL · +17 more sites
RecruitingPhase 3NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Maitland, FL · Merritt Island, FL · +38 more sites
RecruitingPhase 3NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Sponsor: Hoffmann-La Roche
Atlantis, FL · Clermont, FL · Lady Lake, FL · +65 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Boca Raton, FL · Brandon, FL · Fleming Island, FL · +270 more sites
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Boca Raton, FL · Gainesville, FL · +53 more sites
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bradenton, FL · Kissimmee, FL · Largo, FL · +57 more sites
RecruitingPhase 2NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Sponsor: Alveus Therapeutics, Inc.
Bradenton, FL · Doral, FL · Orlando, FL · +17 more sites
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
Brooksville, FL · Clearwater, FL · Hialeah, FL · +98 more sites
RecruitingPhase 3NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Sponsor: Takeda
Aventura, FL · Boca Raton, FL · Clearwater, FL · +50 more sites
RecruitingPhase 1NCT06809400
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Sponsor: Eli Lilly and Company
Maitland, FL · Naples, FL · Orlando, FL · +9 more sites
RecruitingPhase 3NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Boca Raton, FL · Clearwater, FL · Cutler Bay, FL · +205 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Miami, FL · Orlando, FL · Tampa, FL · +9 more sites
RecruitingPhase 4NCT07609914
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Sponsor: Pfizer
Boca Raton, FL · Miami, FL · +18 more sites
RecruitingPhase 2NCT07610473
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Sponsor: Draig Therapeutics Ltd
Hialeah, FL · Orlando, FL · +20 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Hallandale, FL · Lakeland, FL · Miami, FL · +69 more sites
RecruitingNot applicableNCT04101669
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Sponsor: Morphic Medical Inc.
Boynton Beach, FL · Miami, FL · +24 more sites
RecruitingPhase 3NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor: AstraZeneca
Destin, FL · Jacksonville, FL · Kendall, FL · +117 more sites
RecruitingPhase 3NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor: Merck Sharp & Dohme LLC
Altamonte Springs, FL · Gainesville, FL · Orlando, FL · +43 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Clearwater, FL · Fort Myers, FL · Inverness, FL · +84 more sites
RecruitingNot applicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sponsor: Axonics, Inc.
Miami, FL · Orlando, FL · Oxford, FL · +20 more sites
RecruitingPhase 3NCT06736574
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Sponsor: Cytokinetics
Clearwater, FL · Fort Lauderdale, FL · Hollywood, FL · +85 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Altamonte Springs, FL · Orlando, FL · West Palm Beach, FL · +36 more sites
RecruitingPhase 3NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Sponsor: Merck Sharp & Dohme LLC
Fort Myers, FL · Gainesville, FL · Miami Beach, FL · +50 more sites
RecruitingPhase 3NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Sponsor: AstraZeneca
Fort Myers, FL · Miami, FL · Miami Beach, FL · +60 more sites
RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Altamonte Springs, FL · Gainesville, FL · Homestead, FL · +40 more sites
RecruitingPhase 3NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Altamonte Springs, FL · Gainesville, FL · Naples, FL · +31 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.